SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-033345
Filing Date
2019-08-28
Accepted
2019-08-28 16:21:19
Documents
59
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mirm-10q_20190630.htm 10-Q 1672261
2 EX-31.1 mirm-ex311_8.htm EX-31.1 18650
3 EX-31.2 mirm-ex312_9.htm EX-31.2 18668
4 EX-32.1 mirm-ex321_7.htm EX-32.1 9725
5 EX-32.2 mirm-ex322_6.htm EX-32.2 9741
  Complete submission text file 0001564590-19-033345.txt   5722597

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mirm-20190630.xml EX-101.INS 1006050
7 XBRL TAXONOMY EXTENSION SCHEMA mirm-20190630.xsd EX-101.SCH 50050
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mirm-20190630_cal.xml EX-101.CAL 41274
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mirm-20190630_def.xml EX-101.DEF 203238
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mirm-20190630_lab.xml EX-101.LAB 398507
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mirm-20190630_pre.xml EX-101.PRE 316680
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38981 | Film No.: 191062173
SIC: 2834 Pharmaceutical Preparations